You can buy or sell Cidara and other stocks, options, ETFs, and crypto commission-free!
Cidara Therapeutics, Inc. Common Stock, also called Cidara, is a biotechnology company, which engages in the discovery, development, and commercialization of novel anti-infectives. Read More Its product pipeline includes Rezafungin and Cloudbreak. The company was founded by Kevin M. Forrest, Kevin J. Judice, and H. Shaw Warren in December 2012 and is headquartered in San Diego, CA.
San Diego, California
52 Week High
52 Week Low
Research And Development
Cidara Therapeutics Announces Rezafungin Presentations at the 2019 European Society for Blood and Marrow Transplantation Meeting
SAN DIEGO--(BUSINESS WIRE)--Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that three rezafungin abstracts have been accepted for presentation at the 45th Annual European Society for Blood and Marrow Transplantation (EBMT) Meeting to be held in Frankfurt, Germany from March 24-27, 2019. Rezafungin is a novel echinocandin antifungal and is the only once-weekly product candidate in development for the treatment and ...
Simply Wall StMar 5
Read This Before Selling Cidara Therapeutics, Inc. (NASDAQ:CDTX) Shares
We often see insiders buying up shares in companies that perform well over the long term. On the other hand, we’d be remiss not to mention that insider sales have been known to precede tough periods for a business. So before you buy or sell Cidara Therapeutics, Inc. (NASDAQ:CDTX), you may well want to know whether insiders have been buying or selling. What Is Insider Selling? It’s quite normal to see company insiders, such as board members, trading in company stock, from time to time. However, rules gover...
Expected May 9, After Hours